Can Divi's maintain its premium valuation amid headwinds? - Economic Times

7/28/2022 12:00:00 AM2 years 9 months ago
by ET CONTRIBUTORS
by ET CONTRIBUTORS
Indian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resulting in sluggish growth. While price erosion is not the only issue …
SynopsisIndian pharma companies have been struggling to maintain margins because of strong headwinds. Due to increased competition, pharma companies are experiencing price erosion in the market, resu… [+218 chars]
full article...